Noninvasive nuclear factor-kappaB bioluminescence imaging for the assessment of host-biomaterial interaction in transgenic mice
- PMID: 17645941
- DOI: 10.1016/j.biomaterials.2007.07.005
Noninvasive nuclear factor-kappaB bioluminescence imaging for the assessment of host-biomaterial interaction in transgenic mice
Abstract
The inflammatory response is a key component in the biocompatibility of biomaterials. Among the factors that control the development of inflammation is a critical molecule nuclear factor-kappaB (NF-kappaB). Therefore, the aim of this study was to assess the feasibility of noninvasive whole-body real-time imaging for the evaluation of host-biomaterial interaction in the NF-kappaB transgenic mice. Transgenic mice, carrying the luciferase gene under the control of NF-kappaB, were constructed. In vivo bioluminescence imaging showed that the constitutive and induced NF-kappaB activities of transgenic mice were detected in most of the lymphoid tissues, demonstrating that NF-kappaB-driven luminescence reflected the inflammatory response in vivo. By the implantation of genipin-cross-linked gelatin conduit (GGC) and bacterial endotoxin-immersed GGC in the dorsal region, we detected a strong and specific luminescent signal from the tissue around the bacterial endotoxin-immersed GGC implant. Histological and immunohistochemical analysis also demonstrated that inflammation, characterized by the infiltration of immune cells, the accumulation of fluid, and the activation of NF-kappaB, was evoked around the same region. The correlation between the bioluminescence imaging and histological changes indicated that noninvasive imaging technique could be used to monitor the real-time inflammation in the implanted mice.
Similar articles
-
Nuclear factor-kappaB bioluminescence imaging-guided transcriptomic analysis for the assessment of host-biomaterial interaction in vivo.Biomaterials. 2009 Jun;30(17):3042-9. doi: 10.1016/j.biomaterials.2009.02.016. Epub 2009 Feb 27. Biomaterials. 2009. PMID: 19250667
-
[Activation of nuclear factor kappaB (NF-kappaB), induction of proinflammatory cytokines in vitro and evaluation of biocompatibility of the carbonate ceramic in vivo].Polim Med. 2006;36(3):23-35. Polim Med. 2006. PMID: 17190290 Polish.
-
Genipin inhibits lipopolysaccharide-induced acute systemic inflammation in mice as evidenced by nuclear factor-κB bioluminescent imaging-guided transcriptomic analysis.Food Chem Toxicol. 2012 Sep;50(9):2978-86. doi: 10.1016/j.fct.2012.05.054. Epub 2012 Jun 8. Food Chem Toxicol. 2012. PMID: 22687549
-
Molecular imaging of the transcription factor NF-kappaB, a primary regulator of stress response.Mutat Res. 2004 Jul 13;551(1-2):199-211. doi: 10.1016/j.mrfmmm.2004.02.024. Mutat Res. 2004. PMID: 15225593 Review.
-
Bioluminescence imaging.Proc Am Thorac Soc. 2005;2(6):537-40, 511-2. doi: 10.1513/pats.200507-067DS. Proc Am Thorac Soc. 2005. PMID: 16352761 Free PMC article. Review.
Cited by
-
Aspirin Attenuates Hyperoxia-Induced Acute Respiratory Distress Syndrome (ARDS) by Suppressing Pulmonary Inflammation via the NF-κB Signaling Pathway.Front Pharmacol. 2022 Jan 17;12:793107. doi: 10.3389/fphar.2021.793107. eCollection 2021. Front Pharmacol. 2022. PMID: 35111059 Free PMC article.
-
Comprehensive assessment of host responses to ionizing radiation by nuclear factor-κB bioluminescence imaging-guided transcriptomic analysis.PLoS One. 2011;6(8):e23682. doi: 10.1371/journal.pone.0023682. Epub 2011 Aug 24. PLoS One. 2011. PMID: 21887294 Free PMC article.
-
The noninvasive, quantitative, in vivo assessment of adenoviral-mediated gene delivery in skin wound biomaterials.Biomaterials. 2009 Dec;30(35):6788-93. doi: 10.1016/j.biomaterials.2009.07.069. Epub 2009 Sep 24. Biomaterials. 2009. PMID: 19781761 Free PMC article.
-
Kefir peptides alleviate particulate matter <4 μm (PM4.0)-induced pulmonary inflammation by inhibiting the NF-κB pathway using luciferase transgenic mice.Sci Rep. 2019 Aug 8;9(1):11529. doi: 10.1038/s41598-019-47872-4. Sci Rep. 2019. PMID: 31395940 Free PMC article.
-
Comprehensive evaluation of a novel nuclear factor-kappaB inhibitor, quinoclamine, by transcriptomic analysis.Br J Pharmacol. 2009 Jul;157(5):746-56. doi: 10.1111/j.1476-5381.2009.00223.x. Epub 2009 Apr 30. Br J Pharmacol. 2009. PMID: 19422389 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources